Filing Details
- Accession Number:
- 0001209191-18-023598
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-04 16:10:29
- Reporting Period:
- 2018-04-02
- Accepted Time:
- 2018-04-04 16:10:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1001233 | Sangamo Therapeutics Inc | SGMO | Biological Products, (No Disgnostic Substances) (2836) | 680359556 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1324466 | J Steven Mento | C/O Sangamo Therapeutics, Inc. Point Richmond Tech Ctr, 501 Canal Blvd. Richmond CA 94804 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-04-02 | 10,000 | $7.77 | 19,047 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-04-02 | 7,115 | $18.39 | 11,932 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-04-02 | 100 | $18.90 | 11,832 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-04-02 | 10,000 | $0.00 | 10,000 | $7.77 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-06-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 32,214 | Indirect | By Family Trust |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2017.
- The price reported is a weighted average price. The shares were sold at prices ranging from $17.85 to $18.85 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- These shares are held in the Mento Family Trust by Steven J. Mento and Linda A. Mento, Trustees of the Mento Family Trust dated December 29, 1994.
- Fully vested and exercisable.
Billionaire Hedge Funds
